Rating: Hold — Conviction: Low
Conagra is a shrinking, 4x-levered branded food company. The new CEO has halved the dividend, guided EBITDA down again and is reinvesting in advertising. At $14.71 the market already prices roughly the guided FY2027 trough: the stock trades at about 10x guided EPS and near the model's Base value. Leverage makes the equity a thin stub, though. If volumes keep falling it loses most of its value, and if margins stabilize it is worth a good deal more. Without evidence that volume losses are ending, the call is Hold, not a value Buy.
Conviction tests (3a-v-c): T1 fail (Hold → Sell at +1pp: Base midpoint −24.6%; +19.8% at −1pp, a Buy reading) · T2 fail (Gordon DCF alone +11.0% reads Hold; exit DCF −22.2% reads Sell) · T3 pass · T4 pass
Business overview
Conagra sells branded frozen, refrigerated and shelf-stable food in the US, Canada and Mexico, mostly through grocery and mass retail. FY2026 (53 weeks to 2026-05-31) sales were $11.28bn: Refrigerated & Frozen $4.64bn (Birds Eye, Marie Callender's, Healthy Choice, Banquet), Grocery & Snacks $4.61bn (Slim Jim, Duncan Hines, Reddi-wip, Angie's), Foodservice $1.12bn and International $0.91bn. It also owns 44% of Ardent Mills, a flour miller that contributed $141mm of equity earnings in FY2026. Walmart is ~29% of sales, and the top 10 customers are ~60%. Three variables drive earnings: volume (−2.1% in Q1 FY2027), the gap between COGS inflation and price/mix, and A&P reinvestment. Operating profit fell from $1.59bn in FY2022 to −$1.63bn in FY2026, after $2.95bn of impairments, mostly $2.38bn of Refrigerated & Frozen goodwill.
Competition
Conagra's frozen and shelf-stable categories compete with General Mills, Kraft Heinz, Campbell's, J.M. Smucker and Nestlé (Stouffer's/Lean Cuisine, not US-listed), and above all with store brands. Circana puts private label at about 24% of US food and beverage units. In the six months to 2026-06-14, store-brand units rose 0.2% while national brands fell 0.5% (PLMA/Circana via trade press). Pressure shows up first in volume: Grocery & Snacks volume fell 5.4% in Q1 FY2027 even with +3.4% price/mix. It then reaches price, as Refrigerated & Frozen price/mix fell 1.5%. Circana also projects that GLP-1-using households will account for 35% of food and beverage units by 2030, up from ~23% now, a slow headwind for indulgent frozen and snacks. The peer group trades at 11.0–12.9x forward earnings and 8.2–9.2x EV/EBITDA (stockanalysis). Conagra's 10.3x forward multiple sits below all four peers.
Bull case
- Margin restoration — the new CEO's program (productivity, SKU cuts, complexity reduction) recovers about a third of the margin lost since FY2024. Q1 adjusted operating margin of 11.5% already beat the 10.0–10.5% full-year guide. Plays out if COGS inflation eases and the Q1 tariff refunds and productivity gains persist. Model: ebitda_margin
- Volume stabilizes — 15% higher A&P and frozen innovation turn organic sales positive by FY2028. Foodservice (+3.3% organic in Q1) and the frozen-vegetable, chili and frozen-breakfast share gains broaden. Plays out if private label gains stay as measured as Circana's +0.2–0.5pt 2026 outlook. Model: rev_growth
- Deleveraging re-rates the stub — the dividend cut frees ~$335mm a year. Paying down debt takes net leverage from ~4.0x toward 3x by FY2031 (model Base path 4.2x → 3.1x). The EV multiple then moves toward the peer top (~9x), and more of the EV accrues to equity. Plays out if FCF conversion stays >90% as guided. Model: exit_ev_ebitda
Bear case
- Structural volume erosion — private label, GLP-1 adoption and retailer power (Walmart 29%) keep volumes falling 2–3% a year. That is the FY2022–26 pattern, when sales fell from $12.3bn to $11.3bn. Plays out if Q2–Q4 volumes stay at or below Q1's −2.1%. Model: rev_growth
- Margin compression continues — COGS inflation (protein, packaging, freight; Brent ~$113) and A&P reinvestment outrun pricing, as in FY2023. Reinvestment buys no volume. This-basis margin has fallen from 20.7% (FY2022) to 16.5% (FY2026) and ~14.8% guided. Plays out if the adjusted operating margin guide is cut. Model: ebitda_margin
- Leverage and refinancing — $7.76bn of debt against a 4.5x net-leverage covenant (3.99x now). $1.0bn of 1.375% notes due Nov 2027 and $1.68bn due in FY2029 refinance at ~5.4%+. Small EV declines therefore wipe out large shares of equity value. Plays out if EBITDA falls ~10% before debt is repaid. Model: wacc, exit_ev_ebitda
Valuation & balance sheet
| Metric (definition) | Current | Own history (range or 5y avg) | Peers | Source, as-of |
|---|---|---|---|---|
| EV/EBITDA, model basis (no leases; EBITDA incl. Ardent Mills equity earnings) | 7.8x FY2026; 8.0x TTM | n/a (unverified) | lease-inclusive, stockanalysis: GIS 9.2x · KHC 8.3x · CPB 8.2x · SJM 9.2x (CAG 8.7x same basis) | EDGAR XBRL; stockanalysis 2026-10-26 |
| P/E forward (stockanalysis consensus) | 10.3x (10.1x on guide mid $1.45) | n/a (unverified) | GIS 11.0x · KHC 12.5x · CPB 12.2x · SJM 12.9x | stockanalysis 2026-10-26; Q1 FY2027 8-K |
| FCF yield (TTM, stockanalysis) | 12.4% | n/a (unverified) | GIS 8.4% · KHC 13.0% · CPB 11.0% · SJM 11.4% | stockanalysis 2026-10-26 |
| Dividend yield ($0.175/qtr after the cut) | 4.75% | was $0.35/qtr through FY2026 | GIS 7.2% · KHC 6.5% · CPB 4.8% · SJM 3.4% | Q1 FY2027 10-Q; stockanalysis 2026-10-26 |
Model-implied value range (from model-summary.json; generic module, Gordon-growth DCF and exit-EV/EBITDA DCF, midpoints): Bear $1.69 · Base $13.88 · Bull $24.54 per share, i.e. implied returns of −88.5% / −5.6% / +66.8% vs $14.71. These ranges show how the bull and bear drivers translate into value; they are not price targets. The price sits just above Base, so the market pays for roughly the guided trough plus a little stabilization. The distribution is lopsided because of leverage: debt is 52% of EV. The two methods disagree. Base Gordon is $16.33 and exit is $11.44, and Gordon is 43% higher. At a 6.9% WACC and 1% terminal growth, Gordon capitalizes terminal FCF at roughly 17x. That is a re-rating embedded in the Gordon method, while the 7.5x Base exit is a 3.5% de-rating from today's 7.8x. Tail sensitivity, run because the bear case is a slow decline rather than a break: revenue −6%/−4%/−3.5%/−3%/−3%, EBITDA margin falling to 11.5%, 5.5x exit, 8.4% WACC, −0.5% terminal growth → $0.00 (−100%, floored). Base EPS for FY2027 is $1.35 against the $1.40–1.50 guide (see model note).
Balance sheet: net leverage 3.85x FY2026 EBITDA (model basis; 3.99x on the company's TTM adjusted EBITDA of $1,851mm). The Base path runs from 4.2x in Y1 to 3.1x in Y5. EBITDA/interest is 4.9x. Liquidity is $372mm of cash plus an undrawn $2.0bn revolver to June 2030, with no commercial paper outstanding at 2026-08-30. Covenants are net debt/EBITDA ≤4.5x and EBITDA/interest ≥3.0x. Nearest material maturities: $762.5mm of Oct-2026 notes (matured 2026-10-01; $500mm of 5.4% 2031 notes were issued in July), then $1.0bn of 1.375% notes due Nov 2027 and $1.68bn due Oct/Nov 2028. Ratings: investment grade per the 10-Q; agency letters n/a (unverified).
Model note: built and verified (LibreOffice recalculation matched all 3,207 formula cells). Unverified inputs: none. Assumptions without basis: none. Scenario consistency CHECKs: none. Beta is a judgment: measured 5Y beta is about 0, so the CAPM uses 0.80 (est.), and the base WACC adds a stated +0.5pp leverage premium over the 6.43% CAPM WACC. Base FY2027 EPS of $1.35 is 6.9% below the $1.45 guide midpoint because of definitions. Model EBITDA keeps GAAP restructuring, legal and transition charges (~$30mm in Q1) and excludes pension income (~$25mm guided). FY0 cash and debt are at 2026-08-30, so NWC levels are offset by $224mm of Q1 model-basis FCF.
| Metric | CAG | GIS | KHC | CPB | SJM | Peer median | vs median |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | n/a | n/a | n/a | 15.8x | 60.8x | 38.3x | |
| P/E (forward) | 10.2x | 11.0x | 12.4x | 12.2x | 12.9x | 12.3x | −17% |
| PEG | n/a | n/a | n/a | n/a | 2.0x | n/a | |
| EV/EBITDA (TTM) | 8.7x | 9.2x | 8.3x | 8.2x | 9.2x | 8.8x | −0% |
| EV/Sales (TTM) | 1.3x | 1.7x | 1.8x | 1.4x | 2.3x | 1.8x | −28% |
| P/B | 1.1x | 2.5x | 0.8x | 1.6x | 2.4x | 2.0x | −45% |
| FCF yield (TTM) | 12.4% | 8.4% | 13.0% | 11.0% | 11.4% | 11.2% | +1.2pp |
| Dividend yield | 4.8% | 7.2% | 6.5% | 4.8% | 3.4% | 5.6% | −0.9pp |
As of 2026-10-26. One source and one definition for every company: TTM multiples, forward P/E on stockanalysis consensus, EV/EBITDA and EV/Sales on stockanalysis EV and TTM EBITDA. Not the model's own EV basis. Quotes are intraday 2026-10-26, 10:00-10:07 ET, with the market open. Dashed line = peer median. Source: stockanalysis.com /stocks/<ticker>/statistics/, fetched 2026-10-26.
Notes. CAG, GIS and KHC show n/a on the source (TTM GAAP losses from goodwill and brand impairments); SJM's 60.8x is depressed by impairments too. stockanalysis shows no PEG for CAG, GIS, KHC or CPB; SJM's 2.05 is the source's figure. Not computed here. CAG's 4.75% reflects the dividend halved to $0.175 per quarter in 2026.
Scenario stress test
Reasoned from the bull/bear drivers above. The model column comes from the scenario overlays (Base case + shock).
| Scenario | Effect | Mechanism | Magnitude | Model Δ value vs Base ($/sh) |
|---|---|---|---|---|
| S1 Fast equity crash | + | Near-zero-beta staple holds up as a defensive; no operating channel over weeks | Low | +$0.63 |
| S2 Slow bear / recession | − | Staple demand holds, but shoppers trade down to private label and promotion rises; frozen meals partly substitute for restaurants. Far milder than Base − Bear ($12.19) on purpose: two years, not a permanent volume decline | Med | −$1.42 |
| S3 Rapid rate shock | − | Bond-proxy, 4x-levered equity; higher discount rate and refinancing cost on $2.7bn due FY2027–29 | High | −$4.26 |
| S4 Slow rate grind | − | Same channel, slower; maturities roll at higher coupons | Med | −$2.47 |
| S5 Soft-landing cuts | + | Lower rates re-rate yield-sensitive levered staples; cheaper refinancing | High | +$3.08 |
| S6 Recession-driven cuts | + | Rate relief outweighs modest trade-down in a defensive category | Med | +$1.69 |
| S7a Credit liquidity shock | − | Low-BBB issuer at ~4x de-rates with credit; no maturity inside the shock window | Med | −$1.68 |
| S7b Slow default cycle | − | Wider spreads raise refinancing cost; weaker lower-income consumer | Low | −$1.09 |
| S8 Stagflation | − | COGS outruns pricing as in FY2023 while rates stay high | Med | −$2.39 |
| S9a Dollar spike | − | International (~8% of sales, Canada/Mexico) translates lower | Low | −$0.26 |
| S9b Dollar slide | + | Mirror of S9a | Low | +$0.26 |
| S10 Melt-up | − | Rotation out of defensives | Low | −$1.05 |
| S11 Energy supply shock | − | Fuel, freight, packaging and crop-input costs; lower-income shoppers squeezed | Med | −$2.15 |
| S12 Mega-cap/AI derating | + | Rotation into defensives without recession | Low | +$1.05 |
Currently active/on watch per the playbook: S3 partially active; S8, S10 and S11 on watch.
What would change the call
Upgrades if: organic volume turns flat or positive for two consecutive quarters while adjusted operating margin holds ≥10.5%, or net leverage falls below 3.5x with the guide intact. Downgrades if: the FY2027 guide is cut (organic below −3% or adjusted operating margin below 10%), net leverage rises above 4.2x, toward the 4.5x covenant, or there is another Refrigerated & Frozen goodwill impairment (its $4.7bn of goodwill had ≤10% headroom at FY2026).
Watch items
- W1: FY2027 guide — organic −3% to −1%, adjusted operating margin 10.0–10.5%, adjusted EPS $1.40–1.50 reaffirmed or raised — Q2 FY2027 8-K — ~early Jan 2027 — Model: rev_growth, ebitda_margin
- W2: Organic volume — Q2 volume better than Q1's −2.1% (Grocery & Snacks −5.4%) — Q2 FY2027 8-K — ~early Jan 2027 — Model: rev_growth
- W3: Net leverage — ≤4.0x at Q2 and on track for ~4.0x at FY-end (covenant 4.5x) — Q2 FY2027 8-K — ~early Jan 2027 — Model: none
- W4: Refrigerated & Frozen adjusted operating profit — Q1 −13.0% y/y; stabilization vs a further decline and impairment — Q2 FY2027 10-Q — ~early Jan 2027 — Model: ebitda_margin
Sources
- SEC EDGAR XBRL companyfacts, Conagra Brands (CIK 0000023217) — https://data.sec.gov/api/xbrl/companyfacts/CIK0000023217.json — accessed 2026-10-26
- Conagra Brands 10-K FY2026 (filed 2026-07-15) — https://www.sec.gov/Archives/edgar/data/23217/000110465926083905/tmb-20260531x10k.htm — accessed 2026-10-26
- Conagra Brands 10-Q Q1 FY2027 (filed 2026-09-30) — https://www.sec.gov/Archives/edgar/data/23217/000110465926112354/tmb-20260830x10q.htm — accessed 2026-10-26
- Conagra Brands Q1 FY2027 earnings release (8-K ex. 99.1, 2026-09-30) — https://www.sec.gov/Archives/edgar/data/23217/000002321726000052/tmb-ex99d1.htm — accessed 2026-10-26
- Conagra Brands 8-K, 5.400% senior notes due 2031 (2026-07-28) — https://www.sec.gov/Archives/edgar/data/23217/000002321726000032/tmb-20260728x8k.htm — accessed 2026-10-26
- stockanalysis.com statistics: CAG, GIS, KHC, CPB, SJM — https://stockanalysis.com/stocks/cag/statistics/ — accessed 2026-10-26
- Food Business News / PLMA-Circana private label data (midyear 2026; 2025 full year) — https://www.foodbusinessnews.net/articles/30643-private-label-continues-to-pump-out-the-volume — accessed 2026-10-26
- Talk Business, "Private brand sales growth expected to continue in 2026" (Circana GLP-1 projection) — https://talkbusiness.net/2026/04/the-supply-side-private-brand-sales-growth-expected-to-continue-in-2026/ — accessed 2026-10-26
- Yahoo Finance CAG quote (5Y monthly beta ~0) — https://finance.yahoo.com/q?s=CAG&ql=0 — accessed 2026-10-26
- logs/macro-2026-10.md (10Y 5.00%, 2026-10-23) — accessed 2026-10-26